James H. Reamer

Array ( [id] => 1453842 [patent_doc_number] => 06462024 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart' [patent_app_type] => B1 [patent_app_number] => 09/614122 [patent_app_country] => US [patent_app_date] => 2000-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462024.pdf [firstpage_image] =>[orig_patent_app_number] => 09614122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553908 [patent_doc_number] => 06348476 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases' [patent_app_type] => B1 [patent_app_number] => 09/610425 [patent_app_country] => US [patent_app_date] => 2000-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40620 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 325 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348476.pdf [firstpage_image] =>[orig_patent_app_number] => 09610425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625443 [patent_doc_number] => 06723726 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Protein tyrosine kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/608971 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22354 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723726.pdf [firstpage_image] =>[orig_patent_app_number] => 09608971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409698 [patent_doc_number] => 06310051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Use of chelating agents in the treatment of atherosclerotic conditions' [patent_app_type] => 1 [patent_app_number] => 9/599861 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4468 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310051.pdf [firstpage_image] =>[orig_patent_app_number] => 599861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371704 [patent_doc_number] => 06288113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Angiogenesis promoters' [patent_app_type] => 1 [patent_app_number] => 9/486312 [patent_app_country] => US [patent_app_date] => 2000-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4229 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288113.pdf [firstpage_image] =>[orig_patent_app_number] => 486312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1592864 [patent_doc_number] => 06383513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Compositions comprising cannabinoids' [patent_app_type] => B1 [patent_app_number] => 09/595086 [patent_app_country] => US [patent_app_date] => 2000-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3870 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383513.pdf [firstpage_image] =>[orig_patent_app_number] => 09595086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565532 [patent_doc_number] => 06339102 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Method and composition for treating and preventing retinal damage' [patent_app_type] => B1 [patent_app_number] => 09/590174 [patent_app_country] => US [patent_app_date] => 2000-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2658 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339102.pdf [firstpage_image] =>[orig_patent_app_number] => 09590174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360888 [patent_doc_number] => 06255346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Composition for suppressing withdrawal symptoms and craving for alcohol in alcoholics and preventing the abuse of alcohol in healthy subjects' [patent_app_type] => 1 [patent_app_number] => 9/509652 [patent_app_country] => US [patent_app_date] => 2000-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255346.pdf [firstpage_image] =>[orig_patent_app_number] => 509652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274243 [patent_doc_number] => 06245911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Donepezil polycrystals and process for producing the same' [patent_app_type] => 1 [patent_app_number] => 9/555807 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245911.pdf [firstpage_image] =>[orig_patent_app_number] => 555807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478136 [patent_doc_number] => 06344487 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Treatment of insomnia' [patent_app_type] => B1 [patent_app_number] => 09/586706 [patent_app_country] => US [patent_app_date] => 2000-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3355 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344487.pdf [firstpage_image] =>[orig_patent_app_number] => 09586706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277769 [patent_doc_number] => 06281242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Prophylactic or therapeutic agent for amnesia' [patent_app_type] => 1 [patent_app_number] => 9/462099 [patent_app_country] => US [patent_app_date] => 2000-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4466 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281242.pdf [firstpage_image] =>[orig_patent_app_number] => 462099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561711 [patent_doc_number] => 06362194 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists' [patent_app_type] => B1 [patent_app_number] => 09/585517 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 7625 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362194.pdf [firstpage_image] =>[orig_patent_app_number] => 09585517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 718992 [patent_doc_number] => 07048951 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-23 [patent_title] => 'Systems and methods for topical treatment with nitric oxide' [patent_app_type] => utility [patent_app_number] => 10/296110 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6419 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/048/07048951.pdf [firstpage_image] =>[orig_patent_app_number] => 10296110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4338955 [patent_doc_number] => 06284269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Pharmaceutical compositions of meloxicam with improved solubility and bioavailability' [patent_app_type] => 1 [patent_app_number] => 9/486463 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284269.pdf [firstpage_image] =>[orig_patent_app_number] => 486463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459985 [patent_doc_number] => 06391873 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Imidazodiazepine derivative' [patent_app_type] => B1 [patent_app_number] => 09/566832 [patent_app_country] => US [patent_app_date] => 2000-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4641 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391873.pdf [firstpage_image] =>[orig_patent_app_number] => 09566832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238787 [patent_doc_number] => 06166087 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Low dosed 15-deoxyspergualin preparations' [patent_app_type] => 1 [patent_app_number] => 9/446896 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3525 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166087.pdf [firstpage_image] =>[orig_patent_app_number] => 446896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1511361 [patent_doc_number] => 06471961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Interleukin antagonists for the treatment of neurological, retinal and muscular disorders' [patent_app_type] => B1 [patent_app_number] => 09/563651 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4850 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/471/06471961.pdf [firstpage_image] =>[orig_patent_app_number] => 09563651 [rel_patent_id] =>[rel_patent_doc_number] =>)